300 related articles for article (PubMed ID: 15140967)
1. Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.
McMurray HR; McCance DJ
J Virol; 2004 Jun; 78(11):5698-706. PubMed ID: 15140967
[TBL] [Abstract][Full Text] [Related]
2. Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes.
Liu X; Disbrow GL; Yuan H; Tomaic V; Schlegel R
J Virol; 2007 Nov; 81(22):12689-95. PubMed ID: 17804506
[TBL] [Abstract][Full Text] [Related]
3. Bmi-1 cooperates with human papillomavirus type 16 E6 to immortalize normal human oral keratinocytes.
Kim RH; Kang MK; Shin KH; Oo ZM; Han T; Baluda MA; Park NH
Exp Cell Res; 2007 Feb; 313(3):462-72. PubMed ID: 17161394
[TBL] [Abstract][Full Text] [Related]
4. Telomerase activation by the E6 gene product of human papillomavirus type 16.
Klingelhutz AJ; Foster SA; McDougall JK
Nature; 1996 Mar; 380(6569):79-82. PubMed ID: 8598912
[TBL] [Abstract][Full Text] [Related]
5. Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc.
Liu X; Dakic A; Chen R; Disbrow GL; Zhang Y; Dai Y; Schlegel R
J Virol; 2008 Dec; 82(23):11568-76. PubMed ID: 18818322
[TBL] [Abstract][Full Text] [Related]
6. Genomic instability and telomerase activity in human bronchial epithelial cells during immortalization by human papillomavirus-16 E6 and E7 genes.
Coursen JD; Bennett WP; Gollahon L; Shay JW; Harris CC
Exp Cell Res; 1997 Aug; 235(1):245-53. PubMed ID: 9281374
[TBL] [Abstract][Full Text] [Related]
7. Immortalization of normal human embryonic fibroblasts by introduction of either the human papillomavirus type 16 E6 or E7 gene alone.
Yamamoto A; Kumakura S; Uchida M; Barrett JC; Tsutsui T
Int J Cancer; 2003 Sep; 106(3):301-9. PubMed ID: 12845665
[TBL] [Abstract][Full Text] [Related]
8. Impairment of the telomere/telomerase system and genomic instability are associated with keratinocyte immortalization induced by the skin human papillomavirus type 38.
Gabet AS; Accardi R; Bellopede A; Popp S; Boukamp P; Sylla BS; Londoño-Vallejo JA; Tommasino M
FASEB J; 2008 Feb; 22(2):622-32. PubMed ID: 17898088
[TBL] [Abstract][Full Text] [Related]
9. Keratinocyte growth conditions modulate telomerase expression, senescence, and immortalization by human papillomavirus type 16 E6 and E7 oncogenes.
Fu B; Quintero J; Baker CC
Cancer Res; 2003 Nov; 63(22):7815-24. PubMed ID: 14633708
[TBL] [Abstract][Full Text] [Related]
10. HPV16 E7 protein and hTERT proteins defective for telomere maintenance cooperate to immortalize human keratinocytes.
Miller J; Dakic A; Chen R; Palechor-Ceron N; Dai Y; Kallakury B; Schlegel R; Liu X
PLoS Pathog; 2013; 9(4):e1003284. PubMed ID: 23592995
[TBL] [Abstract][Full Text] [Related]
11. HPV E7 contributes to the telomerase activity of immortalized and tumorigenic cells and augments E6-induced hTERT promoter function.
Liu X; Roberts J; Dakic A; Zhang Y; Schlegel R
Virology; 2008 Jun; 375(2):611-23. PubMed ID: 18367227
[TBL] [Abstract][Full Text] [Related]
12. Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity.
Sedman SA; Hubbert NL; Vass WC; Lowy DR; Schiller JT
J Virol; 1992 Jul; 66(7):4201-8. PubMed ID: 1318401
[TBL] [Abstract][Full Text] [Related]
13. Papillomavirus type 16 E6/E7 and human telomerase reverse transcriptase in esophageal cell immortalization and early transformation.
Zhang H; Jin Y; Chen X; Jin C; Law S; Tsao SW; Kwong YL
Cancer Lett; 2007 Jan; 245(1-2):184-94. PubMed ID: 16488074
[TBL] [Abstract][Full Text] [Related]
14. Repression of the human papillomavirus E6 gene initiates p53-dependent, telomerase-independent senescence and apoptosis in HeLa cervical carcinoma cells.
Horner SM; DeFilippis RA; Manuelidis L; DiMaio D
J Virol; 2004 Apr; 78(8):4063-73. PubMed ID: 15047823
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation.
Hebner C; Beglin M; Laimins LA
J Virol; 2007 Dec; 81(23):12740-7. PubMed ID: 17898049
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes.
Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD
Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus type 16 E6 and HPV-16 E6/E7 sensitize human keratinocytes to apoptosis induced by chemotherapeutic agents: roles of p53 and caspase activation.
Liu Y; McKalip A; Herman B
J Cell Biochem; 2000 May; 78(2):334-49. PubMed ID: 10842327
[TBL] [Abstract][Full Text] [Related]
18. The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length.
Stöppler H; Hartmann DP; Sherman L; Schlegel R
J Biol Chem; 1997 May; 272(20):13332-7. PubMed ID: 9148955
[TBL] [Abstract][Full Text] [Related]
19. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells.
Kiyono T; Foster SA; Koop JI; McDougall JK; Galloway DA; Klingelhutz AJ
Nature; 1998 Nov; 396(6706):84-8. PubMed ID: 9817205
[TBL] [Abstract][Full Text] [Related]
20. NFX1-123 and poly(A) binding proteins synergistically augment activation of telomerase in human papillomavirus type 16 E6-expressing cells.
Katzenellenbogen RA; Egelkrout EM; Vliet-Gregg P; Gewin LC; Gafken PR; Galloway DA
J Virol; 2007 Apr; 81(8):3786-96. PubMed ID: 17267499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
